-
1.发明申请公开(公告)号：US20190038628A1
公开(公告)日：2019-02-07
申请号：US16075066
申请日：2017-02-10
Applicant: Novartis AG
Inventor： Bruno BIETH , Christoph BURKHART , Andreas CHRIST , Stefan DE BUCK , Christoph KALIS , Sam LINDGREN
IPC: A61K31/519 , A61P37/00
Abstract: The invention relates to the use of 1-{(S)-3-[6-(6-methoxy-5-trifluoromethyl-pyridin-3-yl)-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-ylamino]-pyrrolidin-1-yl}-propan-1-one or pharmaceutically acceptable salts thereof for the treatment of primary Sjögren's Syndrome.
Search Results
1
records
(took 0.01 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
